ArticleThe Pan African medical journal2025
Assessing mpox epidemic readiness status in ECOWAS region: strengths, gaps, and recommendations for an improved response.
Article in The Pan African medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Mpox outbreak preparedness and response capacity in Nigeria's Federal Capital Territory: a mixed-methods study.BMC public health · 2026Article
- SWOT analysis of Mpox surveillance in high-burden districts in Uganda, February-March 2025.One health outlook · 2026Article
- Strengthening the mpox response: how do we balance pragmatism and equity in resource-constrained settings?Journal of global health · 2025Article
- Confronting the surge of Mpox in West Africa.The Pan African medical journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mpox (formerly known as monkeypox) has re-emerged as a significant public health threat in West Africa, creating new challenges for regional and national health systems. Drawing from past outbreaks, the West African Health Organization (WAHO) has been proactive in enhancing public health preparedness, aligned with WHO recommendations. This study aims to assess the readiness of the ECOWAS region to manage the ongoing mpox outbreak, focusing on critical areas of national epidemic preparedness and response. A survey using the WHO mpox-epidemic readiness checklist tool was conducted in 14 ECOWAS Member States from August 25 to September 15, 2024. Key stakeholders, including Directors of Public Health and Heads of National Public Health Institutes, participated in the assessment. Mpox preparedness meetings and training reports from WAHO were also reviewed to evaluate the region's efforts. A thematic analysis identified key themes, strengths, challenges, and gaps in mpox readiness. The findings revealed considerable variations in readiness across ECOWAS countries. Strengths include established coordination structures, operational surveillance systems, and developed risk communication plans. However, there are major gaps in laboratory capacity, case management, and logistics. Countries such as Liberia and Guinea-Bissau lack sufficient healthcare workers and ICU facilities for managing severe mpox cases. In Senegal and The Gambia, inadequate adaptation and translation of Information, Education, and Communication (IEC) materials hamper public awareness. Logistic challenges, particularly the absence of emergency supply mechanisms and cold chain capacity, also hinder effective responses. Despite progress in mpox preparedness, ECOWAS countries must address significant gaps in laboratory capacity, healthcare infrastructure, and logistics through enhanced coordination and investments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.